News & Events

Even as the national conversation around diversity, equity and inclusion is muted, Weill Cornell Medicine continues its work to make sure everyone has a seat at the table.

That was the message relayed on April 23 by Dr. Linnie Golightly, provost and senior associate dean of academic affairs at CUNY School of Medicine. Dr. Golightly was joined by Dr. Heidi Bender, inaugural associate dean for faculty engagement and inclusion, and Fanesse Acquaye, executive director of the Office of...

Researchers from Weill Cornell Medicine and Boston University School of Public Health have been awarded more than $950,000 from Arnold Ventures to create a “Medicaid Atlas” — a national, data-driven web platform that will illuminate how health care use and spending vary across Medicaid programs, plans and populations. The project will be one of the first major efforts of the...

If it wasn’t for a typo, Dr. William Schpero, a health economist and an assistant professor in population health sciences at Weill Cornell Medicine, may have taken a very different career path.

It was 2010 and he was nearing graduation from Dartmouth College, where he studied biology and government while also writing and editing for the school newspaper. Unsure of whether to pursue a career in medicine or possibly law,...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.” Normally, a B cell matures into a plasma cell that produces antibodies to fight infection, but in this case, the cells are trapped partway through the transition. They switch off key B cell features but never fully mature into functional plasma cells, instead surviving as malignant Hodgkin lymphoma cells, also...

Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate chronic inflammation in the intestine, potentially opening new avenues for therapies against inflammatory bowel disease (IBD), food allergy and other autoimmune conditions.

The...

Caring for a family member with dementia can feel like losing a loved one who is still alive, but a new study suggests that revisiting memories together through a simple digital tool can help ease that grief and even strengthen the patient-caregiver bond. Weill Cornell Medicine and University of Southern California...

Advancing health equity in medicine requires a clear-eyed understanding of history, a rejection of race-based clinical assumptions and a commitment to transform research into practice, said Dr. Joseph L. Wright, senior vice president and chief health equity officer of the American Academy of Pediatrics (AAP), in his keynote address for Weill Cornell Medicine’s eighth annual Diversity Week.

Dr. Wright delivered the...

A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot soldier in the body’s defense against bacterial infection, does not actually help clear invaders the way its close cousin caspase-4 (CASP4) does. Instead, the researchers discovered that CASP5 boosts the signal to proliferate in a population of gut cells that maintains a healthy intestinal lining and replaces injured cells with new, healthy ones.

The...

Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein that has essential roles in all animals. The discovery could lead to new therapeutic strategies for blood coagulation disorders, cancers and other conditions in which the protein, called a TMEM16 scramblase, works abnormally.

Scramblases operate within cell membranes, where they alter or “scramble” the normal layered...

To Dr. Laura Riley, Weill Cornell Medicine’s prowess in caring for women from birth to adulthood is the institution’s best kept secret.

“Weill Cornell is uniquely positioned to provide exemplary care to women, helping them live longer and healthier, and creating evidence for treatment and prevention,” said Dr. Riley, chair of the Department of Obstetrics and Gynecology and the Given Foundation Professor in Clinical Obstetrics and...

Temporarily disabling a protein complex that organizes DNA into loops inside the cell’s nucleus drastically disrupted the three-dimensional structure of the genome, but surprisingly most genes continued to function as usual, Weill Cornell Medicine researchers found. However, they also discovered a small group of affected genes that play a critical role in guiding cells to become specific types, for example heart, brain, or liver cells.

The...

A team of Weill Cornell Medicine investigators is working to cross-train the next generation of cancer researchers in cancer biology and the use of artificial intelligence tools for research.

As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers are advocating for evidence-based health care policy reform and expanded Medicaid coverage for children. Weill Cornell Medicine’s Department of Pediatrics, the Cornell Health Policy Center (CHPC) and Ariadne Labs are collaborating to launch the Era of the Child...

Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas—blood cancers that arise in immune cells called B cells—yet the same is not true for patients with more rare lymphoma types that originate in immune cells called T cells.

Peripheral T-cell lymphomas comprise diverse blood cancers that have a distinct biology, and survival rates vary widely. Lymphoma specialist Dr....

A $1 million Research Scholar Grant from the American Cancer Society will help a multi-institution team led by Dr. Bishoy Faltas, associate professor of medicine at Weill Cornell Medicine, to develop new therapy combinations for hard-to-treat urinary tract cancers.

New...

Alzheimer’s disease may not be a single illness, but a complex web of overlapping brain disorders that scientists have just started to untangle. Leaders in the field discussed this shift in research at the recent 13th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium held in the Belfer Research Building at Weill Cornell Medicine.

“The vision of the Appel Institute is simple. We wanted to tackle some of the most devastating...

Family physicians who report feeling burned out are nearly 1.5 times more likely to change practices or stop practicing medicine entirely compared to their peers who don’t report burnout, a study by Weill Cornell Medicine researchers found. Physician burnout can include emotional exhaustion,...

Six researchers from Weill Cornell Medicine have received Young Investigator Awards from the Prostate Cancer Foundation. These three-year grants award $225,000 to postdoctoral fellows and early-career faculty, helping to energize the field with fresh ideas. The Weill Cornell investigators are part of thirty-one researchers overall who were selected for the PCF’s Class of 2025 Young Investigators. The awardees will investigate how the disease occurs at a molecular level, search for new...

NEW YORK (March 25, 2026)—Dr. Y. Michael Shim, an esteemed physician-scientist who specializes in advanced pulmonary imaging and obstructive airway diseases, has been named chief of the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective April 1.

The division provides expert, comprehensive care for...

Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at Weill Cornell Medicine, Cornell Tech, Cornell Ann S. Bowers College of Computing and Information Science, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian—offers the prospect of better care for many thousands of patients who may be overlooked due to the...